Journal of Neurology

, Volume 241, Issue 8, pp 475–480 | Cite as

A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1

  • J. Zielasek
  • G. Ritter
  • S. Magi
  • H. P. Hartung
  • K. V. Toyka
Original Communication

Abstract

IgM class antibodies against the ganglioside GM1 have been found in a subgroup of patients with lower motor neuron syndromes and multifocal motor neuropathies (MMN). The pathogenic relevance of these antibodies is still unclear, but some MMN patients with IgM antibodies against GM1 seem to profit from immunosuppressive therapy. A reliable test for IgM antibodies against GMl may be useful for identifying these patients. We have assessed the comparability of the ELISA tests used for the determination of IgM against GM1 by sending coded serum samples to nine laboratories. In three samples high-titre IgM antibodies against GM1 were detected by all laboratories. This result was confirmed by dot blot immunodetection and thin-layer chromatography immuno-overlay. Seven samples were read as negative by nearly all laboratories. Major discrepancies between laboratories were noted in the analysis of one sample with results ranging from negative to “high titre”.

Key words

Lower motor neuron syndrome Multifocal motor neuropathy Anti-ganglioside antibodies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams D, Kuntzer T, Burger D, Chofflon M, Magistris MR, Regli F, Steck AJ (1991) Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 32:223–230Google Scholar
  2. 2.
    Ben Younes-Chennoufi A, Meininger V, Leger JM, Bouche P, Jauberteau MO, Baumann N (1992) Antiganglioside antibodies in motor-neuron diseases and peripheral neuropathies: study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int 20:353–357Google Scholar
  3. 3.
    Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 34:136–144Google Scholar
  4. 4.
    Feldman EL, Bromberg MB, Albers JW, Pestronk A (1991) Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30:397–401Google Scholar
  5. 5.
    Gregson NA, Jones D, Thomas PK, Willison HJ (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol 238:447–451Google Scholar
  6. 6.
    Harlow E, Lane D (1988) Antibodies. A laboratory manual. Cold Spring Harbour Laboratory Books, Cold Spring Harbour, NY, p 403Google Scholar
  7. 7.
    Hartung HP, Stoll G, Toyka KV (1993) Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo IF (eds) Peripheral neuropathy, 3rd edn. Saunders, Philadelphia, pp 418–444Google Scholar
  8. 8.
    Ilyas AA, Mithen FA, Chen ZW, Cook SD (1992) Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J Neuroimmunol 36:69–76Google Scholar
  9. 9.
    Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD (1992) Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. J Neurol Sci 107:111–121Google Scholar
  10. 10.
    Lamb NL, Patten BM (1991) Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies. Muscle Nerve 14:1021–1027Google Scholar
  11. 11.
    Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, Blake DM, Hirano M, Burns SM, Lovelace RE, Rowland LP (1992) Multifocal motor neuropathy with con duction block: is it a distinct clinical entity? Neurology 42:497–505Google Scholar
  12. 12.
    Marcus DM, Latov N, Hsi BP, Gillard BK and participating laboratories (1989) Measurement and significance of antibodies against GMI ganglioside. J Neuroimmunol 25:255–259Google Scholar
  13. 13.
    Pestronk A (1991) Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies (invited review). Muscle Nerve 14:927–936Google Scholar
  14. 14.
    Pestronk A, Comblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN (1988) A treatable mutlifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24:73–78Google Scholar
  15. 15.
    Pestronk A, Chaudry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, Glasberg M, Kuncl RW, Olney RK, Yee WC (1990) Loser motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titres of antiglycolipid antibodies. Ann Neurol 27:316–326Google Scholar
  16. 16.
    Ritter G, Boosfeld E, Markstein E, Yu RK, Ren S, Stallcup WB, Oettgen HF, Old LJ, Livingston PO (1990) Biochemical and serological characteristics of natural 9-0-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3. Cancer Res 50:1403–1410Google Scholar
  17. 17.
    Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, Romas SN, Kumar N, Berg L van den, Santoro M, Lange DJ, Younger DS, Lovelace RE, Trojaborg W, Sherman WH, Miller JR, Minuk J, Fehr MA, Roelofs RI, Hollander D, Nichols FT, Mitsumoto H, Kelley JJ Jr, Swift TR, Munsat TL, Latov N (1990) The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40:1067–1072Google Scholar
  18. 18.
    Salazar-Grueso EF, Routbort MJ, Martin J, Dawson G, Roos RP (1990) Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol 27:558–563Google Scholar
  19. 19.
    Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, Latov N, Hays AP (1990) IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, antiGMI antibodies, and multifocal motor conduction block. Ann Neurol 28:373–377Google Scholar
  20. 20.
    Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, Latov N (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 31:385–390Google Scholar
  21. 21.
    Schluep M, Steck AJ (1988) Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 38:1890–1892Google Scholar
  22. 22.
    Shy ME, Heiman-Patterson T, Parry GJ, Tahmoush A, Evans VA, Schick PK (1990) Lower motor neuron disease in a patient with auto-antibodies against Gal (β1-3) GaINAc in gangliosides GM1 and GD1b: improvement following immunotherapy. Neurology 40:842–844Google Scholar
  23. 23.
    Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P (1993) Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 114:49–55Google Scholar
  24. 24.
    Steck AJ (1990) Antibodies in the neurology clinic. Neurology 40:1489–1492Google Scholar
  25. 25.
    Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, Hays AP (1991) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 82:378–383Google Scholar
  26. 26.
    Toyka KV, Hartung HP (1992) Circulating immune factors. In: Asbury AK, McKhann GM, McDonald WI (eds) Diseases of the nervous system: clinical neurobiology, 2nd edn, vol II. Saunders, Philadelphia, pp 1396–1409Google Scholar
  27. 27.
    Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N (1993) Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16:610–615Google Scholar
  28. 28.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL (1993) Serum antibodies to GMI, GDlb, peripheral nerve myelin, andCampylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 34:130–135Google Scholar
  29. 29.
    Walsh FS, Cronin M, Koblar S, Doherty P, Winer J, Leon A, Hughes RAC (1992) Association between glycoconjugate antibodies andCampylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 34:43–51Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • J. Zielasek
    • 1
  • G. Ritter
    • 2
  • S. Magi
    • 1
  • H. P. Hartung
    • 1
  • K. V. Toyka
    • 1
  1. 1.Department of NeurologyJulius-Maximilians-UniversitätWürzburgGermany
  2. 2.FIDIA Research LaboratoriesAbano TermeItaly

Personalised recommendations